Taro Pharmaceutical Industries (TARO) SEC Filings & 10K Form

$42.40
-0.08 (-0.19%)
(As of 04/26/2024 ET)

Recent Taro Pharmaceutical Industries SEC Filings

DateFilerForm TypeView
04/15/2024
5:07 AM
Taro Pharmaceutical Industries (Subject)
Form SC 13E3/A
03/20/2024
3:32 PM
Taro Pharmaceutical Industries (Subject)
Form SC 13E3/A
03/11/2024
5:19 AM
Taro Pharmaceutical Industries (Subject)
Form SC 13E3/A
02/15/2024
7:36 AM
Taro Pharmaceutical Industries (Subject)
Form SC 13E3
01/26/2024
8:00 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2024
3:36 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2024
3:35 PM
SUN PHARMACEUTICAL INDUSTRIES LTD (Filed by)
Taro Pharmaceutical Industries (Subject)
Form SC 13D/A
12/11/2023
3:30 PM
SUN PHARMACEUTICAL INDUSTRIES LTD (Filed by)
Taro Pharmaceutical Industries (Subject)
Form SC 13D/A
12/11/2023
3:31 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/17/2023
3:30 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/27/2023
8:00 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/27/2023
9:00 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2023
3:32 PM
Taro Pharmaceutical Industries (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
06/28/2023
4:00 PM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2023
10:55 AM
Taro Pharmaceutical Industries (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:TARO) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners